50 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Anika Therapeutics, Inc. ANIK surged 35.1% to $55.15 after the company reported better-than-expected Q2 sales results.
• TCR2 Therapeutics Inc. TCRR gained 30.1% to $13.20.
• Diebold Nixdorf, Incorporated DBD rose 24.5% to $12.81 after the company reported better-than-expected Q2 EPS and sales results. The company also raised FY19 sales guidance.
• Gemphire Therapeutics Inc. GEMP shares climbed 22% to $0.8540 after the company announced a merger with NeuroBO Pharmaceuticals.
• Hovnanian Enterprises, Inc. HOV rose 22% to $7.10.
• Rekor Systems, Inc. REKR gained 20.5% to $4.82.
• EDAP TMS S.A. EDAP shares climbed 17% to $3.10 after the company reported preliminary Q2 sales are up 45% from last year.
• NETGEAR, Inc. NTGR gained 16.4% to $33.02 after the company reported better-than-expected Q2 EPS and sales results. The company also issued Q3 sales guidance on the high end analyst estimates and announced a $4.5 million buyback.
• Meritage Homes Corporation MTH rose 15.8% to $62.98 after the company reported better-than-expected Q2 EPS and sales results. Citi also upgraded the company's stock from Neutral to Buy.
• ADOMANI, Inc. ADOM jumped 14.8% to $0.2754 after the company reported better-than-expected Q2 sales results. The company also reported a Q2 net loss of $1.3 million vs $4.2 million in the same quarter last year.
• Onconova Therapeutics, Inc. ONTX gained 14.4% to $2.63. Noble Capital initiated coverage on Onconova Therapeutics with an Outperform rating and a $12 price target.
• Live Oak Bancshares, Inc. LOBrose 13.8% to $19.24 following upbeat Q2 earnings.
• Aeglea BioTherapeutics, Inc. AGLE gained 13.3% to $8.10. Aeglea Bio Therapeutics said the FDA granted Breakthrough Therapy Designation to its lead investigational therapy pegzilarginase, for the treatment of Arginase 1 Deficiency, a rare progressive disease presenting in early childhood that results in severe complications and early mortality.
• Pluristem Therapeutics Inc. PSTI climbed 12.6% to $4.7958.
• AgeX Therapeutics, Inc. AGE rose 11.4% to $2.4850.
• Universal Forest Products, Inc. UFPI rose 9.8% to $39.46 after the company reported better-than-expected Q2 EPS results.
• scPharmaceuticals Inc. SCPH gained 8.9% to $5.74.
• Nokia Corporation NOK shares rose 8.6% to $5.62 after the company reported better-than-expected Q2 results.
• Ambev S.A. ABEV climbed 7.8% to $5.10 after the company reported better-than-expected Q2 EPS and sales results.
• TechnipFMC plc FTI rose 5.7% to $27.88 after the company reported better-than-expected Q2 EPS and sales results.
• AstraZeneca PLC AZN rose 5.6% to $42.62 after the company reported better-than-expected Q2 EPS and sales results. The company also extended its 2017 development agreement with BioCardia.
• Anheuser-Busch InBev SA/NV BUD shares rose 3.7% to $99.10 after reporting strong Q2 results.

Check out these big penny stock gainers and losers

Losers

• Align Technology, Inc. ALGN shares tumbled 27.4% to $199.72 after the company issued Q3 EPS and sales guidance below analyst estimates. Evercore ISI Group downgraded the company's stock from Outperform to In-Line and lowered the price target from $340 to $220.
• Spirit Airlines, Inc. SAVE dropped 21.7% to $43.13 after multiple firms downgraded the company's stock following the release of the company's Q2 results.
• World Acceptance Corporation WRLD fell 20.3% to $130.46 following Q1 results. Janney Capital downgraded World Acceptance from Neutral to Sell and lowered the price target from $108 to $87.
• NextGen Healthcare, Inc. NXGN shares declined 20.1% to $16.40 after reporting Q1 results. Dougherty downgraded NextGen Healthcare from Neutral to Sell.
• PTC Inc. PTC fell 19.9% to $73.34 after the company reported Q3 results and lowered its FY19 guidance.
• Lantheus Holdings, Inc. LNTH fell 17.8% to $23.78 after the company reported downbeat Q2 sales and lowered FY2019 guidance.
• Oceaneering International, Inc. OII fell 17.3% to $15.98 after the company reported worse-than-expected Q2 EPS and sales results.
• LendingTree, Inc. TREE dipped 16.6% to $345.00 after the company reported worse-than-expected Q2 EPS results.
• Martin Midstream Partners L.P. MMLP fell 16.6% to $5.64 after reporting Q2 results.
• Altra Industrial Motion Corp. AIMC dropped 16.4% to $30.06 after the company reported worse-than-expected Q2 EPS and sales results. The company issued FY19 EPS and sales guidance below analyst estimates.
• Flexible Solutions International Inc. FSI shares declined 16.4% to $3.2776.
• Innoviva, Inc. INVA tumbled 14.5% to $11.14.
• Akerna Corp. KERN dropped 14.2% to $11.73.
• Tesla, Inc. TSLA fell 14% to $227.80 after the company reported worse-than-expected Q2 EPS and sales results.
• Obalon Therapeutics, Inc. OBLN dropped 13.1% to $4.9715.
• Cara Therapeutics, Inc. CARA fell 12% to $23.13. Cara Therapeutics priced its 5.5 million share offering of common stock at $23 per share.
• CoreLogic, Inc. CLGX dipped 11.6% to $41.75 following Q2 results.
• Antero Resources Corporation AR dropped 10.5% to $4.4025.
• Unit Corporation UNT dropped 9.4% to $6.76
• TAL Education Group TAL fell 9.4% to $33.99 after reporting quarterly results.
• Ford Motor Company F fell 7.8% to $9.52 after reporting second-quarter earnings. The company issued weak 2019 earnings guidance.
• QIAGEN N.V. QGEN fell 5.7% to $37.80 following Q2 results.
• Banco Bradesco S.A. BBD dropped 5.3% to $9.72 after the company reported Q2 results.
• American Airlines Group Inc. AAL dropped 4.7% to $32.96 after the company reported Q2 results.
• PayPal Holdings, Inc. PYPL fell 4.2% to $116.25. PayPal reported upbeat earnings for its second quarter, while sales missed estimates. The company also issued 2019 sales guidance below analyst estimates.
• RELX PLC RELX fell 4.1% to $23.28 following weak sales.
• ServiceNow, Inc. NOW shares dropped 3.8% to $285.84 after the company reported Q2 results and issued Q3 guidance.
• Xilinx, Inc. XLNX fell 3.4% to $127.68 after the company issued its Q2 sales guidance below analyst estimates.